|
Biotecnologia Aplicada
Elfos Scientiae
ISSN: 0684-4551
Vol. 14, Num. 1, 1997, pp. 50
|
Biotecnologia Aplicada 1997 Volume 14 No. 1, pp.50
GANGLIOSIDE VACCINES: ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES AS ANTIGEN
SURROGATES
Eladio Iglesias, Ana Maria Vazquez, Gumersinda Bombino, Amparo Macias,
Irene Beausoleil and Rolando Perez
Center of Molecular Immunology, P.O. Box 16040. Havana, Cuba.
Code Number:BA97014
Size of Files:
Text: 3.9K
Graphics: No associated graphics files
Introduction
Gangliosides, which are glycolipids containing sialic acid in their
structure, have demonstrated to be important tumor-associated antigens due
to their differential expression in tumoral tissues in comparison with
their normal counterparts (1).
Different immunotherapeutic approaches have been used to obtain an
effective immune response against cells expressing defined gangliosides.
One of these approaches is the use of anti-idiotypic MAbs as antigen
surrogates (2, 3).
We have previously described the obtention of an IgM murine MAb, named P3,
generated by the immunization of Balb/c mice with purified GM3 (NeuGc)
included in liposomes (4). This MAb recognizes the N-glycolyl variants of
different gangliosides. Also, P3 MAb reacted with antigens expressed in
breast cancer cell lines and malignant human tissues of this origin. In
this paper we reported our results in the generation and primary
characterization of anti-idiotypic MAbs against P3 MAb.
Materials and Methods
Balb/c mice were immunized with two doses (50 ug/dose) of P3 MAb coupled
with KLH, in the presence of Freund's adjuvant. Animals with high anti-
idiotypic antibody response against P3 MAb (1/50 000) were sacrificed and
the spleen cells were fused with the murine myeloma cell line
P3X63Ag8.653.
Hybrid culture supernatants were screened by ELISA against different anti-
ganglioside IgM MAbs. Hybridomas secreting antibodies specific to P3 MAb
were selected. Further characterization included the study of their
blocking capacity of P3 MAb binding to GM3 (NeuGc) by ELISA, and their
ability to generate antibody response against this ganglioside when they
were injected coupled with KLH and emulsified in Freund's adjuvant in
syngeneic and allogeneic mice.
Results and Discussion
Seven IgG1 anti-idiotypic MAbs were obtained. All of them reacted strongly
with P3 MAb and no reactivity was observed with the other anti-ganglioside
IgM MAbs tested. The seven anti-idiotypic MAbs had the capacity to block P3
MAb binding to GM3 (NeuGc), in a concentration range between 1 to 10
ug/mL.
Five of these anti-idiotypic MAbs were capable to elicit a humoral response
against GM3(NeuGc) with antibody titers ranged between 1/320-1/1280, in
both syngeneic and allogeneic mice, but the specificity of this response
differed from P3 MAb recognition due to the reactivity of animal sera not
only with N-glycolyl containing gangliosides but also with N-acetyl
variants. This anti-ganglioside antibody response generated by the
immunization with the anti-idiotypic MAbs resembled the humoral responses
raised when animals were immunized with GM3(NeuGc) ganglioside included in
liposomes.
Ongoing studies are directed to elucidate the capacity of these anti-
idiotypic MAbs to develop a humoral anti-idiotypic response in xenogeneic
models and also, to define their possible anti-tumoral effects in vivo.
References
1. Hakomori S. Cancer Research 1985; 45:2405-14.
2. Houghton A, B Chapman. J Clin Invest 1991;88:186-192.
3. Irie RF et al. J Natl Cancer Inst 1990; 82:1757-1760.
4. Vazquez AM et al. Hybridoma 1995; 14:551-556.
Copyright 1997 Elfos Scientiae
|